Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/28/2006 | WO2006137209A1 Dna, vector, transformant and method for producing apa protein |
12/28/2006 | WO2006136953A2 Method of producing organotypic cell cultures |
12/28/2006 | WO2006136951A2 Murine stem cells and applications thereof |
12/28/2006 | WO2006136351A2 Methods for altering the reactivity of plant cell walls |
12/28/2006 | WO2006136244A2 Use of adipose tissue-derived stromal stem cells in treating fistula |
12/28/2006 | WO2006136164A1 Mutant cells suitable for recombinant polypeptide production |
12/28/2006 | WO2006136114A1 Amniotic cells and methods for use thereof |
12/28/2006 | WO2006136006A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth |
12/28/2006 | WO2006119467A3 Protein activity modification |
12/28/2006 | WO2006117483A3 Synthetic and standardized prion infectuous material, and uses thereof as an infecting inoculum |
12/28/2006 | WO2006113731A3 Bone marrow-derived neurogenic cells and uses thereof |
12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
12/28/2006 | WO2006099448A3 Accelerated cd8+ t-cell memory after dendritic cell vaccination |
12/28/2006 | WO2006089911A3 Expression cassettes for seed-preferential expression in plants |
12/28/2006 | WO2006083394A3 Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
12/28/2006 | WO2006083275A3 Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof |
12/28/2006 | WO2006074397A3 Cripto binding molecules |
12/28/2006 | WO2006073671A8 Protein activity modification |
12/28/2006 | WO2006040615A3 Differenciation of stem cells for therapeutic use |
12/28/2006 | WO2006036745A3 Il-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses |
12/28/2006 | WO2005103231A3 Dentritic cells charged with toxic substances in order to treat kidney cell carcinomas |
12/28/2006 | WO2005090406A3 Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
12/28/2006 | WO2005079271A3 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
12/28/2006 | WO2005054295A3 Therapeutic and diagnostic anti-hsp 70 antibodies |
12/28/2006 | WO2005045025A3 Cloning and characterization of 5’ flanking regions of a human aggrecanase-1 gene |
12/28/2006 | WO2003072714A3 Follistatin domain containing proteins |
12/28/2006 | US20060294627 Inbred corn line G0502 |
12/28/2006 | US20060294625 Disease-resistant transgenic canola plants; glucosinolate level of <30 mu moles per gram of oil-free solid; oilseed containing <2% erucic acid; extracting crude oil from crushed seeds, refining to rape oil for food use; blackleg resistance; plant cells; genetic engineering |
12/28/2006 | US20060294624 Alfalfa Variety 53V52 |
12/28/2006 | US20060294622 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
12/28/2006 | US20060294618 imparting virus resistance to plants by silencing a gene encoding a translation initiation factor eIF4E or by overexpressing in a plant a nucleic acid molecule encoding a heterologous eIF4E |
12/28/2006 | US20060294614 Orphan receptors; drug screening; host cells |
12/28/2006 | US20060294613 Mo54 Disruptions, Compositions and Methods Related Thereto |
12/28/2006 | US20060294611 WIP, a WASP-associated protein |
12/28/2006 | US20060294610 Alpha1-3 galactosyltransferase gene and promoter |
12/28/2006 | US20060294609 Production of cloned offspring from cooled carcasses |
12/28/2006 | US20060294604 Model for studying the role of genes in tumor resistance to chemotherapy |
12/28/2006 | US20060294603 Cloning of transgenic animals comprising artificial chromosomes |
12/28/2006 | US20060294602 Diagnostic and therapeutic use of a rab family gtp-binding protein for neurodegenerative diseases |
12/28/2006 | US20060293239 Treatment and Diagnosis of Insulin-Resistant States |
12/28/2006 | US20060293230 Expression and secretion of icIL-1 receptor antagonist type II |
12/28/2006 | US20060293225 Gmg-2 polynucleotides and polypeptides and uses thereof |
12/28/2006 | US20060292695 Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells |
12/28/2006 | US20060292694 Reporter hepatocytes and other cells for drug screening and toxicity testing |
12/28/2006 | US20060292693 comprises a heavy chain variable region and a light chain variable region produced by mouse hybridoma cell line 1G3; capable of neutralizing EV71 infection |
12/28/2006 | US20060292692 Nutrient broth for propagation mammalian tissue models for use in nutraceutical discovery, drug screening, pharmacokinetics and transplantation studies |
12/28/2006 | US20060292690 Method of making cell growth surface |
12/28/2006 | US20060292689 CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis |
12/28/2006 | US20060292688 System and sequential culture media for in vitro fertilization |
12/28/2006 | US20060292687 Methods for modulating floral organ identity, modulating floral organ number, increasing of meristem size, and delaying flowering time |
12/28/2006 | US20060292673 For degradation of glycosaminoglycans; inhibiting angiogenesis and cellular proliferation; treating cancer, neurodegenerative disease, atherosclerosis and microbial infection |
12/28/2006 | US20060292672 Cell lines for expressing enzyme useful in the preparation of amidated products |
12/28/2006 | US20060292670 Nell peptide expression systems and bone formation activity of nell peptide |
12/28/2006 | US20060292667 Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone |
12/28/2006 | US20060292655 2-O sulfatase compositions and methods of analyzing therewith |
12/28/2006 | US20060292644 Novel tumor-associated marker |
12/28/2006 | US20060292643 Recognition molecules for the treatment and detection of tumours |
12/28/2006 | US20060292636 Quantum (TM) phytase; high sensitivity and specificity for the phytase and are useful in immunoassay methods; capable of detecting low concentrations of phytase |
12/28/2006 | US20060292621 Randomized libraries of zinc finger proteins |
12/28/2006 | US20060292620 Genes with ES cell-specific expression |
12/28/2006 | US20060292593 Nucleotide sequences coding B7 immune response regulatory protein selectively expressed on dendritic cells for use as therapeutic tool in targeting viral and tumor cell for destruction |
12/28/2006 | US20060292587 Polynucleotides encoding insect voltage-gated chloride channel and uses thereof |
12/28/2006 | US20060292577 Neoplasia-specific splice variants and methods |
12/28/2006 | US20060292563 Methods of diagnosing & treating diabetes and insulin resistance |
12/28/2006 | US20060292548 Using channel protein and immobilized nerve to identify inhibitors of bitter and/or sweet taste preception |
12/28/2006 | US20060292546 Herg channel-expressing cell |
12/28/2006 | US20060292180 Contacting the sample with an isolated antibody specific for an EspA polypeptide, wherein the polypeptide is a secreted protein from enteropathogenic E. coli, detecting binding of the antibody to EspA polypeptide |
12/28/2006 | US20060292177 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
12/28/2006 | US20060292168 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
12/28/2006 | US20060292166 Vaccine composition comprising Flt3-ligand |
12/28/2006 | US20060292161 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections |
12/28/2006 | US20060292156 Recombinant lymphocyte expressing Fc receptor for use in targeting and destroying viral infection and tumor tissues |
12/28/2006 | US20060292154 A34 and a33-Like 3dna, proteins, antibodies thereto and methods of treatment using same |
12/28/2006 | US20060292152 used for the for the medical diagnosis and treatment of Alzheimer's disease |
12/28/2006 | US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin |
12/28/2006 | US20060292139 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
12/28/2006 | US20060292138 Fusion proteins comprising an allergen sequence linked via an IgG hinge region to another polypeptide sequence capable of specifically binding to a native IgG inhibitory receptor containing an immune receptor tyrosine based inhibitory motif |
12/28/2006 | US20060292132 Neuroprotective effective compound |
12/28/2006 | US20060292131 Chondrocyte Therapeutic Delivery System |
12/28/2006 | US20060292130 2-O sulfatase nucleic acid compositions |
12/28/2006 | US20060292129 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof |
12/28/2006 | US20060292128 Methods of treating schizophrenia |
12/28/2006 | US20060292127 Beta cell growth and differentiation |
12/28/2006 | US20060292126 Epidermal and dermal equivalents |
12/28/2006 | US20060292125 Methods for treating ischemic tissue |
12/28/2006 | US20060292123 Adeno-associated virus-mediated delivery of GDNF to skeletal muscles |
12/28/2006 | DE19931819B4 11-Arachidonat-Lipoxygenase-Mutante Arachidonate 11-lipoxygenase mutant |
12/28/2006 | DE102005028899A1 Verfahren zur Erzeugung eines Hautäquivalents A method for producing a skin equivalent |
12/28/2006 | CA2850323A1 Methods and compositions involving mirna and mirna inhibitor molecules |
12/28/2006 | CA2633030A1 Intralesional treatment of psoriasis |
12/28/2006 | CA2620946A1 Amniotic cells and methods for use thereof |
12/28/2006 | CA2613457A1 Use of adipose tissue-derived stromal stem cells in treating fistula |
12/28/2006 | CA2613257A1 A novel biological substance nesfatin and its related substances and uses thereof |
12/28/2006 | CA2613160A1 Methods for altering the reactivity of plant cell walls |
12/28/2006 | CA2612269A1 Method of producing organotypic cell cultures |
12/28/2006 | CA2612252A1 Methods and compositions for gene silencing |
12/28/2006 | CA2612021A1 Compositions and methods for treating and diagnosing cancer |
12/28/2006 | CA2611519A1 Ilt3 binding molecules and uses therefor |
12/28/2006 | CA2609077A1 Lgi, lingo and p75ntr family members: novel modulators of neuronal growth |
12/28/2006 | CA2607859A1 Murine stem cells and applications thereof |